Vanguard Group Inc. Purchases 44,684 Shares of Cemex S.A.B. de C.V. $CX

Vanguard Group Inc. raised its position in Cemex S.A.B. de C.V. (NYSE:CX) by 1.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 3,908,186 shares of the construction company’s stock after acquiring an additional 44,684 shares during the period. Vanguard Group Inc. owned about 0.27% of Cemex worth $21,925,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Wayfinding Financial LLC bought a new stake in Cemex in the 1st quarter valued at approximately $29,000. Barclays PLC lifted its stake in Cemex by 56.2% in the 4th quarter. Barclays PLC now owns 9,759 shares of the construction company’s stock valued at $55,000 after acquiring an additional 3,510 shares in the last quarter. Raiffeisen Bank International AG bought a new stake in Cemex in the 4th quarter valued at approximately $59,000. Westfuller Advisors LLC bought a new stake in Cemex in the 1st quarter valued at approximately $62,000. Finally, Sargent Investment Group LLC bought a new stake in Cemex in the 1st quarter valued at approximately $62,000. Institutional investors own 82.97% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CX. Itau BBA Securities lowered Cemex from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 3rd. JPMorgan Chase & Co. raised Cemex from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $8.10 to $10.50 in a research report on Tuesday. Wall Street Zen raised Cemex from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Barclays boosted their price target on Cemex from $9.00 to $10.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 29th. Four investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $8.53.

Cemex Stock Performance

Shares of NYSE CX opened at $9.08 on Friday. The stock’s fifty day moving average price is $8.01 and its two-hundred day moving average price is $6.85. The firm has a market cap of $13.15 billion, a price-to-earnings ratio of 8.90, a P/E/G ratio of 0.95 and a beta of 1.40. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.86 and a quick ratio of 0.61. Cemex S.A.B. de C.V. has a one year low of $4.89 and a one year high of $9.19.

Cemex (NYSE:CX) last released its earnings results on Thursday, July 24th. The construction company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.20 billion. Cemex had a return on equity of 6.89% and a net margin of 9.61%. On average, equities analysts forecast that Cemex S.A.B. de C.V. will post 0.69 EPS for the current year.

Cemex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Tuesday, June 17th were given a dividend of $0.0224 per share. This represents a $0.09 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Tuesday, June 17th. Cemex’s dividend payout ratio is presently 7.84%.

Cemex Company Profile

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.